Vertex’s Povetacicept BLA Accepted by US FDA for IgA Nephropathy

Vertex Pharmaceuticals has received US FDA acceptance of its Biologics License Application for accelerated approval of p...

June 4, 2026 | Thursday | News
Omnix Medical Announces First Patients Dosed in Phase II Trial of Antimicrobial Lead Compound OMN6

Omnix Medical, a biopharmaceutical company developing next-generation anti-infectives for severe multidrug-resistant inf...

June 4, 2026 | Thursday | News
Thermo Fisher Scientific Unveils Next-generation Innovations at ASMS 2026 to Accelerate Drug Discovery

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced the Thermo Scientific Orbitrap...

June 3, 2026 | Wednesday | News
Singapore becomes first APAC market to approve MSD's Enflonsia for infant RSV prevention

MSD, trade name of Merck & Co., Inc., Rahway, N.J., USA, has announced that the Health Sciences Authority (HSA) of S...

June 2, 2026 | Tuesday | News
Insilico Medicine and Human Longevity to co-develop industry-first AI foundation model for longevity science

Insilico Medicine, a Hong Kong-headquartered clinical-stage generative artificial intelligence (AI)-driven biotechnology...

May 28, 2026 | Thursday | News
China Formalises Regulatory Data Protection Measures for Drug Applications

On May 15, 2026, China’s National Medical Products Administration (“NMPA”) issued the Implementat...

May 21, 2026 | Thursday | News
AMR innovation faces growing investment gap despite rising global health threat

Antimicrobial resistance (AMR) continues to be recognised as one of the world’s most pressing ...

May 14, 2026 | Thursday | Opinion
South Korea’s Biopharma Expansion Signals Next Decade Of Global Innovation Growth At API China 2026

Reporting on ground from API China 2026, BioSpectrum Asia observed strong international interest aro...

May 14, 2026 | Thursday | News
4D Path partners with Daiichi Sankyo to advance AI-driven ADC programme

4D Path, a US-based company dedicated to personalising cancer care through a novel, physics-informed approach to predict...

April 15, 2026 | Wednesday | News
Expecto Health Science Partners with Neuratrial to Pioneer AI-Driven CRO Operating Model

Expecto Health Science, a full-service Asia-Pacific Contract Research Organization (CRO),  announced a strategic pa...

April 8, 2026 | Wednesday | News
Insilico Medicine inks $2.75 B global R&D collaboration with Eli Lilly

Insilico Medicine, a clinical-stage biotechnology company powered by generative artificial intelligence (AI) and automat...

March 30, 2026 | Monday | News
Insilico Medicine and Tenacia Biotech expand AI-driven CNS collaboration worth $94.75 M

Hong Kong headquartered Insilico Medicine, a clinical-stage generative artificial intelligence (AI)-driven biotechnology...

March 30, 2026 | Monday | News
SK pharmteco and Prozomix collaborates to enhance Biocatalysis capabilities for global drug manufacturing

SK pharmteco, a leading global contract development and manufacturing organization (CDMO), and Prozomix, a pioneer ...

March 25, 2026 | Wednesday | News
Insilico Medicine and ASKA Pharma expand partnership to discover novel targets for women’s health

Hong Kong headquartered Insilico Medicine, a clinical-stage drug discovery and development company driven by genera...

March 25, 2026 | Wednesday | News
Singapore's EDDC launches R&D collaboration with Daiichi Sankyo to advance Next‑Gen NK Cell engagers

The Experimental Drug Development Centre (EDDC), Singapore’s national platform for drug discovery and development ...

March 24, 2026 | Tuesday | News
Digital Manufacturing Must Lead The Next Phase Of Cell And Gene Therapy Scale Up

In conversation with Ankit Kankar, General Manager at BioSpectrum Asia, Alexander Seyf, CEO and co found...

March 12, 2026 | Thursday | News
Heath Coats Highlights Evolving FDA Inspection Expectations At Charles River APAC Biomanufacturing Leadership Summit

In his keynote session, Heath Coats shared practical regulatory insights drawn from his experience both ...

March 10, 2026 | Tuesday | News
Collaboration between Israel and Australia to advance AI-driven cancer therapeutics

Israel-based Evogene has announced a collaboration with the pioneering research group of Dr Mark Adams, a leading c...

February 20, 2026 | Friday | News
Japan's Daiichi Sankyo collaborates with BostonGene to accelerate AI-based drug development

US-based BostonGene, the developer of the leading AI foundation model for tumour and immune biology, has announced ...

February 18, 2026 | Wednesday | News
Korean startup Galux raises $29 M to advance AI-driven protein design for drug discovery

Galux, a South Korea-based biotech startup pioneering artificial intelligence (AI)-driven protein therapeutics design, h...

February 17, 2026 | Tuesday | News
Japan's Veritas In Silico partners with SpiroChem for discovery of next generation RNA drugs

Swiss firm SpiroChem AG and Japan-based Veritas In Silico Inc. have announced the signing of a Memorandum of Understandi...

January 28, 2026 | Wednesday | News
Pierre Fabre Laboratories Bets On Generative AI With Iktos To Reimagine The Future Of Oncology Drug Discovery

Pierre Fabre Laboratories and Iktos, a global leader in Artificial Intelligence (AI) and Robotics on drug discovery, ann...

January 9, 2026 | Friday | News
Iktos And Servier Enter Strategic AI Led Drug Discovery Collaboration Valued At Over €1 Billion

Iktos, a leader in Artificial Intelligence (AI) and Robotics applied to drug discovery, announced a landmark multi-targe...

January 8, 2026 | Thursday | News
Insilico Medicine announces $888 M multi-year collaboration with Servier for drug discovery in oncology

Hong Kong headquartered Insilico Medicine, a leading artificial intelligence (AI)-driven drug discovery company, has ann...

January 5, 2026 | Monday | News
Japan's Meiji Seika Pharma collaborates with MBC BioLabs for global innovation in drug discovery

Japan-based Meiji Seika Pharma has entered into a partnership agreement with MBC BioLabs which is a private organisation...

December 19, 2025 | Friday | News